Parkside Financial Bank & Trust

Bank

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1455267 SAINT LOUIS, MO

Position in HALO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$316,040

+$63,060 QoQ

Shares Held

4,890

+30.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Parkside Financial Bank & Trust holds $38,819,782 across 131 Biotechnology names. HALO ranks #3 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	1,329,164	$36,817,842
2	VRTX	Vertex Pharmaceuticals Inc / Ma	735	$328,206
3	HALO	Halozyme Therapeutics, Inc. This page	4,890	$316,040
4	TECH	BIO-TECHNE Corp	3,722	$194,511
5	REGN	Regeneron Pharmaceuticals, Inc.	194	$149,891
6	CPRX	Catalyst Pharmaceuticals, Inc.	4,027	$99,708
7	MRNA	Moderna, Inc.	1,807	$91,794
8	DNTH	Dianthus Therapeutics, Inc. /DE/	1,050	$88,116

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$316,040	4,890	+30.1%	Shares	Sole	2026-05-13
2025-12-31	$252,980	3,759	+3.0%	Shares	Sole	2026-02-13
2025-09-30	$267,543	3,648	-9.1%	Shares	Sole	2025-10-30
2025-06-30	$208,859	4,015	-3.5%	Shares	Sole	2025-08-07
2025-03-31	$265,385	4,159	+131.1%	Shares	Sole	2025-05-08
2024-12-31	$86,057	1,800	+21.8%	Shares	Sole	2025-02-05
2024-09-30	$84,600	1,478	+18.6%	Shares	Sole	2024-11-07
2024-06-30	$65,239	1,246	-33.2%	Shares	Sole	2024-08-05
2024-03-31	$75,908	1,866	+7.7%	Shares	Sole	2024-05-01
2023-12-31	$64,051	1,733	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.